QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Anti-PD-L1 mediating tumor-targeted codelivery of liposomal irinotecan/JQ1 for chemo-immunotherapy 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 8 作者:  He, Zhi-di;  Zhang, Meng;  Wang, Yong-hui;  He, Yang;  Wang, Hai-rui 收藏  |  浏览/下载：32/0  |  提交时间：2021/05/24 tumor-targeted delivery  immunogenic cell death  PD-1  PD-L1 blockade  tumor immune microenvironment  irinotecan  JQ1  immune checkpoint   Immune microenvironment features and efficacy of PD-1/PD-L1 blockade in non-small cell lung cancer patients with EGFR or HER2 exon 20 insertions 期刊论文 THORACIC CANCER, 2020 作者:  Chen, Kaiyan;  Pan, Guoqiang;  Cheng, Guoping;  Zhang, Fanrong;  Xu, Yanjun 收藏  |  浏览/下载：39/0  |  提交时间：2020/12/28 EGFR  HER2  immunotherapy  NSCLC  PD‐  L1   Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1 期刊论文 NANO LETTERS, 2019, 卷号: 19, 期号: 5, 页码: 2935-2944 作者:  Wang, Hairui;  Tang, Yisi;  Fang, Yuefei;  Zhang, Meng;  Wang, Huiyuan 收藏  |  浏览/下载：14/0  |  提交时间：2020/07/01 Biomimetic delivery  glucose metabolism  immunogenic cell death (ICD)  tumor-associated macrophage  shikonin  JQ1   Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors 期刊论文 THERANOSTICS, 2019, 卷号: 9, 期号: 16 作者:  Lu, Jia-Cheng;  Zeng, Hai-Ying;  Sun, Qi-Man;  Meng, Qing-Nan;  Huang, Xiao-Yong 收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05 intrahepatic cholangiocarcinoma  hepatitis B virus  hepatolithiasis  programmed cell death protein 1  programmed cell death protein ligand 1  immune checkpoint blockage